About
Ipsogen develops molecular diagnostic assays specialized in oncology, focusing on detecting and monitoring hematological malignancies such as leukemias through genetic markers and minimal residual disease testing.
Explore Ipsogen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.